China Passes Japan In R&D, But Which Country Is Smarter?

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

The Battelle Memorial Institute, which looks at R&D in major nations, says that China will pass Japan as the No.2 spender next year. “China is expected to spend $153.7 billion on R&D in 2011, up from the $141.4 billion it will spend this year,” The Wall Street Journal reports. “Japan is expected to spend $144.1 billion next year, up from $142 billion in 2010.”

The U.S. holds the lead position with R&D expenditures expected to top $400 billion next year.

Battelle data is not terribly detailed. It does show that China has spent a good deal to advance alternative energy. That may not be important in a country like the US which has abundant coal and hydro-electric power reserves. America may even increase the output of nuclear energy as it looks at France where most electricity is generated by reactors.

China remains weak in intellectual property. It has not been able to produce the kind of technology which has created huge companies such as Microsoft (NASDAQ: MSFT), Amgen (NYSE: AMGN), Pfizer (NYSE: PFE), Google (NASDAQ: GOOG), Cisco (NASDAQ: CSCO) or Intel (NASDAQ: INTC).

China still must import products built using most complex technology and there is little evidence that it can create its own software or biopharma sectors. China remains an exporter of products based on relatively crude research.

China’s goal is to wean itself away from technology created in the US, Japan, and some parts of Europe. That may take decades. Until that time, finished goods which represent almost all of its exports will be the staple of its economic growth. That represents a problem. The People’s Republic must rely on raw goods to feed its factories. That means it is a hostage to inflation.

American R&D largely creates products and services which are not affected by inflation. Software creation and manufacturing costs do not rely much on outside goods. Neither does the manufacturing of complex drugs. This contrast works in the favor of the US, and China and may not be able to ever close that gap.

Douglas A. McIntyre

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618